Application of rhG-CSF in patients with plasma cell disease treated with autologus peripheral blood stem cell transplantation / 中国癌症杂志

20?10 6/L were observed in the blood. No patients presented bone pain, fever, abnormal function of liver and kidney, and so on. Conclusions:Our results indicated that rhG-CSF is efficacious and safe in auto-PBSCT for patients with plasma cell diseases. Therefore, the expense of hospitalization would be reduced significantly.